T
COLL icon

TCWP’s Collegium Pharmaceutical COLL Stock Holding History

TCWP’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24
Closed – – 600
2022
Q1 		$0 Buy
+24
New +$453 ﹤0.01% 1764

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TCWP's COLL Position: Q2 2022 in Review

TCWP sold out of Collegium Pharmaceutical (COLL) in Q2 2022, closing a stake of 24 shares.

TCWP first reported a position in COLL in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 157 funds tracked by Wall St. Rank hold COLL as of Q2 2022.

  • TCWP reported no remaining Collegium Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • TCWP sold 24 Collegium Pharmaceutical shares in Q2 2022.
  • TCWP first reported a position in Collegium Pharmaceutical in Q1 2022 and held it in 1 quarter.
  • TCWP's Collegium Pharmaceutical position peaked at $0 in Q1 2022.
  • 157 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.